Literature DB >> 22511142

De-escalation: in drug we trust.

Philippe Montravers, Pascale Piednoir, Nicolas Allou.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22511142     DOI： 10.1097/CCM.0b013e31824317bb

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  3 in total

1.  Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.

Authors:  Peter Liu; Christopher Ohl; James Johnson; John Williamson; James Beardsley; Vera Luther
Journal:  BMC Infect Dis       Date:  2016-12-12       Impact factor: 3.090

2.  Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial.

Authors:  Luis Eduardo López-Cortés; Clara Rosso-Fernández; María Núñez-Núñez; Lucía Lavín-Alconero; José Bravo-Ferrer; Ángel Barriga; Mercedes Delgado; Carmen Lupión; Pilar Retamar; Jesús Rodríguez-Baño
Journal:  BMJ Open       Date:  2017-06-09       Impact factor: 2.692

3.  Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients.

Authors:  Leslie Gonzalez; Aurélie Cravoisy; Damien Barraud; Marie Conrad; Lionel Nace; Jérémie Lemarié; Pierre-Edouard Bollaert; Sébastien Gibot
Journal:  Crit Care       Date:  2013-07-12       Impact factor: 9.097
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.